The real concern for your future

Between 04.09.11 and 08.09.11, AO “Pharm-Sintez” participated in the 7th International Conference on Isotopes

09.09.2011

Between 04.09.11 and 08.09.11, AO “Pharm-Sintez” participated in the 7th International Conference on Isotopes (ICI7), held in the World Trade Center in Moscow.

International conference on isotopes gathers leading scientists in this field as well as top managers of major nuclear companies. During this conference various aspects of radioisotopes application were discussed and special attention was paid to the properties of atomic nucleus in practical medicine. Application of new isotopes and radiopharmaceutical products in nuclear medicine was the most urgent issue in the conference.

In the nuclear medicine session “Pharm-Sintez” company presented report on the new unique radiopharmaceutical product Rezoscan, 99mTc for skeleton scintillography and single-photon emission computerized tomography (SPECT):

1. “Rezoscan, 99mTc in diagnostic of metastatic skeleton damage”
V.N. Korsunsky, V.N. Oshchepkov, S.V. Shiryaev
A.I. Burnazyan Federal Medical and Biophysical Center, N.N. Blokhin Russian Cancer Research Center and Research Institute of Urology

Also new AO “Pharm-Sintez” product – radiopharmaceutical product for positron emission skeleton tomography with generator-produced isotope 68Ga – was presented:

2. “PET in oncology: 68Ga: Modern status and prospects”
S. Stepanov, E. Rabinovich, L. Voloznev

On the Rosatom recommendation, for the first time conference schedule, in addition to plenary and breakout sessions and exposition of the newest solutions in isotope production, included business program, during which participants was given opportunity to discuss issues of creating favorable investment environment, expanding possibilities of isotope application and increasing production capabilities. In this section Petrov T.V., General Director of AO “Pharm-Sintez”, talked about Russian nuclear medicine development and prospects and presented company`s design solutions for treatment and diagnostic radioisotope complexes as well as their advantages for practical medicine:

“Advantages of treatment and diagnostic radioisotope complexes application in practical medicine”
T.V. Petrov

During the conference new radiopharmaceutical products for diagnostic and therapy, solutions in the field of generator-produced systems for nuclear medicine and other challenging subjects were discussed as well.